JPH08208480A - 改良された溶解速度を持つネファゾドンの塩 - Google Patents

改良された溶解速度を持つネファゾドンの塩

Info

Publication number
JPH08208480A
JPH08208480A JP7281241A JP28124195A JPH08208480A JP H08208480 A JPH08208480 A JP H08208480A JP 7281241 A JP7281241 A JP 7281241A JP 28124195 A JP28124195 A JP 28124195A JP H08208480 A JPH08208480 A JP H08208480A
Authority
JP
Japan
Prior art keywords
nefazodone
salt
dissolution rate
salts
tartrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP7281241A
Other languages
English (en)
Japanese (ja)
Inventor
Hemant N Joshi
エヌ ジョシー ヘマント
Terry D Wilson
ディ ウィルソン テリー
Jatin M Patel
エム パテル ジャティン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of JPH08208480A publication Critical patent/JPH08208480A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP7281241A 1994-11-02 1995-10-30 改良された溶解速度を持つネファゾドンの塩 Pending JPH08208480A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33339094A 1994-11-02 1994-11-02
US333390 1994-11-02

Publications (1)

Publication Number Publication Date
JPH08208480A true JPH08208480A (ja) 1996-08-13

Family

ID=23302579

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7281241A Pending JPH08208480A (ja) 1994-11-02 1995-10-30 改良された溶解速度を持つネファゾドンの塩

Country Status (10)

Country Link
US (1) US6034085A (de)
EP (1) EP0710653B1 (de)
JP (1) JPH08208480A (de)
AT (1) ATE157659T1 (de)
AU (1) AU689645B2 (de)
CA (1) CA2160423A1 (de)
DE (1) DE69500652T2 (de)
DK (1) DK0710653T3 (de)
ES (1) ES2107280T3 (de)
GR (1) GR3025376T3 (de)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002512965A (ja) * 1998-04-24 2002-05-08 スカリスタ リミティッド 鬱病の治療およびそのための薬学的調製物
JP2002528505A (ja) * 1998-11-02 2002-09-03 アルザ・コーポレーション 抗鬱剤の制御送達

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030118645A1 (en) * 1998-04-29 2003-06-26 Pather S. Indiran Pharmaceutical compositions for rectal and vaginal administration
US6974590B2 (en) 1998-03-27 2005-12-13 Cima Labs Inc. Sublingual buccal effervescent
US20030091629A1 (en) * 1998-03-27 2003-05-15 Cima Labs Inc. Sublingual buccal effervescent
ES2152860B1 (es) * 1998-10-23 2001-08-16 Finaf 92 Sa Forma cristalina de la nefazodona y procedimiento para su preparacion.
US7087372B2 (en) * 2001-01-18 2006-08-08 Idexx Laboratories, Inc. Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies
US20030194756A1 (en) * 2002-04-12 2003-10-16 O'connor Thomas Patrick Peptides for detection of antibody to Ehrlichia equi
US7183060B2 (en) * 2005-02-22 2007-02-27 Idexx Laboratories, Inc. Peptides for detection of antibody to Ehrlichia ewingii
US7407770B2 (en) * 2001-01-18 2008-08-05 Idexx Corporation Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies
US20030129680A1 (en) * 2001-10-31 2003-07-10 O'connor Thomas Patrick Multi-analyte assay device
US20030068356A1 (en) * 2001-07-10 2003-04-10 Pather S. Indiran Sequential drug delivery systems
GB0217056D0 (en) * 2002-07-23 2002-08-28 Ass Octel Use
TWI335218B (en) * 2003-02-19 2011-01-01 Panion & Bf Biotech Inc Ferric organic compounds, uses thereof and methods of making same
AU2004311879B2 (en) * 2003-12-31 2010-08-05 Phoenix Labs Unlimited Company Effervescent oral opiate dosage form
US7858121B2 (en) * 2003-12-31 2010-12-28 Cima Labs, Inc. Effervescent oral fentanyl dosage form and methods of administering fentanyl
CA2548915C (en) * 2003-12-31 2012-10-16 Cima Labs Inc. Generally linear effervescent oral fentanyl dosage form and methods of administering
US20060063735A1 (en) * 2004-09-17 2006-03-23 Supergen, Inc. Salts of 5-azacytidine
US20060069060A1 (en) * 2004-09-27 2006-03-30 Sanjeev Redkar Salts of decitabine
US7507789B2 (en) * 2007-04-09 2009-03-24 Idexx Laboratories, Inc. Detection of Anaplasma platys
US7964366B2 (en) 2007-09-21 2011-06-21 Idexx Laboratories, Inc. Methods and compositions for detection of Ehrlichia chaffeensis (VLPT)
BRPI0816437B8 (pt) * 2007-09-21 2021-05-25 Idexx Lab Inc polipeptídeos purificados e métodos para a detecção de ehrlichia chaffeensis em uma amostra teste
US8158370B2 (en) * 2007-11-27 2012-04-17 Idexx Laboratories, Inc. Anaplasma phagocytophilum (Aph) antigens and antibodies specific for Anaplasma
KR20110086027A (ko) * 2008-10-08 2011-07-27 아이덱스 래보러토리즈, 인코포레이티드 아나플라즈마 파고사이토필럼（Ａｐｈ） 및 아나플라즈마 플라티스（Ａｐｌ）에 특이적인 항체의 검출 방법 및 조성물
WO2010099508A1 (en) 2009-02-26 2010-09-02 Theraquest Biosciences, Inc. Extended release oral pharmaceutical compositions of 3-hydroxy-n-methylmorphinan and method of use
WO2012072665A1 (en) 2010-11-30 2012-06-07 Pharmaneuroboost N.V. Compositions comprising pipamperone and serotonin antagonist reuptake inhibitors
US9133525B2 (en) 2012-01-26 2015-09-15 Luc Montagnier Detection of DNA sequences as risk factors for HIV infection
CN117797108B (zh) * 2024-01-02 2025-06-27 山东新时代药业有限公司 一种富马酸比索洛尔组合物片剂

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1066857B (it) * 1965-12-15 1985-03-12 Acraf Derivati della s ipiazolo 4.3 a piridina e processi per la loro preparazione
US4487773A (en) * 1981-03-16 1984-12-11 Mead Johnson & Company 1,2,4-Triazol-3-one antidepressants
US4338317A (en) * 1981-03-16 1982-07-06 Mead Johnson & Company Phenoxyethyl-1,2,4,-triazol-3-one antidepressants
IT1196429B (it) * 1986-07-01 1988-11-16 Mediolanum Farmaceutici Srl Processo per la preparazione di pirido benzotiazine ad attivita' antibatterica e loro sali con acidi solfonici
US5188836A (en) * 1990-07-27 1993-02-23 Warner-Lambert Company Sustained release formulations
TW279864B (de) * 1993-02-19 1996-07-01 Janssen Pharmaceutica Nv

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002512965A (ja) * 1998-04-24 2002-05-08 スカリスタ リミティッド 鬱病の治療およびそのための薬学的調製物
JP2002528505A (ja) * 1998-11-02 2002-09-03 アルザ・コーポレーション 抗鬱剤の制御送達

Also Published As

Publication number Publication date
DE69500652D1 (de) 1997-10-09
ATE157659T1 (de) 1997-09-15
DE69500652T2 (de) 1998-02-19
AU689645B2 (en) 1998-04-02
AU3458395A (en) 1996-05-09
DK0710653T3 (da) 1997-12-08
GR3025376T3 (en) 1998-02-27
EP0710653B1 (de) 1997-09-03
EP0710653A1 (de) 1996-05-08
US6034085A (en) 2000-03-07
CA2160423A1 (en) 1996-05-03
ES2107280T3 (es) 1997-11-16

Similar Documents

Publication Publication Date Title
JPH08208480A (ja) 改良された溶解速度を持つネファゾドンの塩
KR102841419B1 (ko) sGC 자극제를 포함하는 고체 분산물
US12152009B2 (en) Crystalline substituted pyrazines as PGI2 receptor agonists
JP6731001B2 (ja) ボルチオキセチンピログルタミン酸塩
JP2013063999A (ja) 抗核形成剤を含有する医薬組成物
SK302003A3 (en) Stable gabapentin having pH within a controlled range
JP2006528948A (ja) ピオグリタゾン塩、例えば硫酸ピオグリタゾン、およびそれを使用した医薬組成物および方法
RU2834293C2 (ru) Кристаллическое вещество
CN110678464A (zh) 马赛替尼的晶型
HK40105478A (en) Crystal
WO2022034914A1 (ja) 易溶性固形製剤およびその製法
HK40026685A (en) Crystal
JP2006506360A (ja) パーキンソン病の治療のための医薬組成物
JPH023609A (ja) 塩酸ニカルジピンを活性成分とする持効性製剤
RU2448967C2 (ru) Соли производных пирролопиримидинона и способ их получения

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20061017

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20070327